Back to Journals » Cancer Management and Research » Volume 12

Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

Total article views   Abstract views HTML views PDF downloads Totals
2,092 Dovepress* 1,560 263+ 479 1,823
PubMed Central* 0 269 77 269
Totals 1,560 532 556 2,092
*Since 23 June 2020
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar